Literature DB >> 8591996

Extracellular matrix regulates the amount of the beta-amyloid precursor protein and its amyloidogenic fragments.

F C Bronfman1, C Soto, L Tapia, V Tapia, N C Inestrosa.   

Abstract

We have studied the influence of the extracellular matrix (ECM) on the amount of beta-amyloid precursor protein (APP) and C-terminal amyloid-bearing fragments in 313 fibroblasts. After incubation with ECM components, the cellular APP content of 3T3 cells changed. Besides, different substrata including collagen, fibronectin, laminin, vitronectin, and heparin, determined changes in the amount of a C-terminal 22 kDa-fragment. The regulation of amyloidogenic fragments by the ECM was transient; in fact, when 3T3 cells were plated on tissue culture dishes coated with collagen or vitronectin, maximal levels of the 22 kDa fragment were observed 12 h after plating; in the presence of fibronectin, the maximum level of the amyloidogenic fragment was obtained 36 h after plating. These results indicate that the ECM modulates in a transient way the generation of APP-derived polypeptides containing the amyloid-beta-peptide (A beta). The ECM does not have a generalized effect on 3T3 fibroblasts, because no significant differences in cell attachment, growth rate, whole-cell polypeptide pattern beta 1 integrin and alpha-tubulin levels were observed on cells grown on various matrix proteins. Laminin, collagen, and heparin also influence the level of an amyloidogenic fragment of 35 kDa in Neuro 2A neuronal cells, without a significant change in the neuronal marker acetylcholinesterase. In this case, however, a long-lasting response to ECM molecules was observed. These observations provide evidence that ECM molecules influence APP biogenesis, including the generation of amyloidogenic fragments containing the A beta peptide. Our studies might prove significant to understand the localized increment of beta-amyloid deposition in selected areas of the brain of Alzheimer's patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8591996     DOI: 10.1002/(SICI)1097-4652(199602)166:2<360::AID-JCP14>3.0.CO;2-F

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

Review 1.  Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer's disease pathogenesis.

Authors:  M T Gentile; M G Reccia; P P Sorrentino; E Vitale; G Sorrentino; A A Puca; L Colucci-D'Amato
Journal:  Mol Neurobiol       Date:  2012-05-31       Impact factor: 5.590

Review 2.  Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease.

Authors:  N C Inestrosa; M P Marzolo; A B Bonnefont
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

3.  MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits.

Authors:  Martin Winter; Andreas Tholey; Sandra Krüger; Hartmut Schmidt; Christoph Röcken
Journal:  J Histochem Cytochem       Date:  2015-06-22       Impact factor: 2.479

Review 4.  The Role of Extracellular Matrix Components in the Spreading of Pathological Protein Aggregates.

Authors:  Edoardo Moretto; Skye Stuart; Sunaina Surana; Jose Norberto S Vargas; Giampietro Schiavo
Journal:  Front Cell Neurosci       Date:  2022-04-29       Impact factor: 6.147

5.  Seeding and Growth of β-Amyloid Aggregates upon Interaction with Neuronal Cell Membranes.

Authors:  Álvaro Ruiz-Arias; Jose M Paredes; Chiara Di Biase; Juan M Cuerva; María D Giron; Rafael Salto; Juan A González-Vera; Angel Orte
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

6.  Multi-omic analyses in Abyssinian cats with primary renal amyloid deposits.

Authors:  Francesca Genova; Simona Nonnis; Elisa Maffioli; Gabriella Tedeschi; Maria Giuseppina Strillacci; Michela Carisetti; Giuseppe Sironi; Francesca Anna Cupaioli; Noemi Di Nanni; Alessandra Mezzelani; Ettore Mosca; Christopher R Helps; Peter A J Leegwater; Laetitia Dorso; Maria Longeri
Journal:  Sci Rep       Date:  2021-04-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.